Display options
Cite
Wasfy S, Nishikawa J, Petric M. Seroprevalence of immunoglobulin G antibody to parvovirus B19 in Ontario. Can J Infect Dis. 1996;7(5):313-6doi: 10.1155/1996/941356.
Wasfy, S., Nishikawa, J., & Petric, M. (1996). Seroprevalence of immunoglobulin G antibody to parvovirus B19 in Ontario. The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses, 7(5), 313-6. https://doi.org/10.1155/1996/941356
Wasfy, S, et al. "Seroprevalence of immunoglobulin G antibody to parvovirus B19 in Ontario." The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses vol. 7,5 (1996): 313-6. doi: https://doi.org/10.1155/1996/941356
Wasfy S, Nishikawa J, Petric M. Seroprevalence of immunoglobulin G antibody to parvovirus B19 in Ontario. Can J Infect Dis. 1996 Sep;7(5):313-6. doi: 10.1155/1996/941356. PMID: 22514456; PMCID: PMC3327426.
Copy Download .nbib Format: NLM
Share it on

Can J Infect Dis. 1996 Sep;7(5):313-6. doi: 10.1155/1996/941356.

Seroprevalence of immunoglobulin G antibody to parvovirus B19 in Ontario.

The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses

S Wasfy, J Nishikawa, M Petric

Affiliations

  1. Virology Laboratory, Division of Microbiology, The Hospital for Sick Children, Toronto, Ontario.

PMID: 22514456 PMCID: PMC3327426 DOI: 10.1155/1996/941356

Abstract

The prevalence of antibody to parvovirus B19 was assessed in two populations. In a group of 494 residents from Ontario and the Maritimes, virus-specific immunoglobulin (Ig) M antibody, a marker of acute infection, was found throughout the year but was most prevalent during the late winter and early spring months. The overall prevalence of IgG antibody in this group was 30.3%. In an effort to examine age-specific prevalence in this population, a second group of sera from 210 pediatric patients at The Hospital for Sick Children, Toronto, Ontario and from Red Cross blood donors was tested for the presence of B19-specific IgG, and of these, 31.4% of the samples were positive. This prevalence varied from 3.3% in the under five-year-old age group to 66.7% in the 35- to 45-year-old age group. Eighty per cent of sera from females of this group were seropositive. This study provides insight into the prevalence of parvovirus B19 IgG antibody in the population.

Keywords: Human parvovirus B19; Seroprevalence

References

  1. J Hyg (Lond). 1983 Aug;91(1):113-30 - PubMed
  2. Lancet. 1988 Nov 19;2(8621):1159-62 - PubMed
  3. Lancet. 1975 Jan 11;1(7898):72-3 - PubMed
  4. Pediatr Infect Dis J. 1987 Aug;6(8):711-8 - PubMed
  5. Lancet. 1985 Feb 23;1(8426):422-5 - PubMed
  6. J Clin Microbiol. 1994 Jun;32(6):1457-63 - PubMed
  7. J Hyg (Lond). 1984 Aug;93(1):85-93 - PubMed
  8. N Engl J Med. 1987 Jul 30;317(5):287-94 - PubMed
  9. Lancet. 1985 Feb 23;1(8426):419-21 - PubMed
  10. J Clin Microbiol. 1986 Oct;24(4):522-6 - PubMed
  11. N Engl J Med. 1985 Jul 11;313(2):74-9 - PubMed
  12. Lancet. 1992 Jan 11;339(8785):107-9 - PubMed
  13. N Engl J Med. 1987 Jan 22;316(4):183-6 - PubMed
  14. Lancet. 1984 Nov 3;2(8410):1033-4 - PubMed
  15. J Infect Dis. 1986 Sep;154(3):383-93 - PubMed
  16. Pediatr Infect Dis J. 1989 Feb;8(2):83-7 - PubMed
  17. J Infect Dis. 1993 Aug;168(2):361-8 - PubMed
  18. Proc Natl Acad Sci U S A. 1991 Jun 1;88(11):4646-50 - PubMed
  19. Lancet. 1981 Sep 19;2(8247):595-7 - PubMed
  20. J Med Virol. 1991 Oct;35(2):110-5 - PubMed

Publication Types